Evaluation of the efficacy and safety of different dilutions of Mesobotox in Mid and / or lower face rejuvenation: Interventional study

Abstract

Abstract As life expectancy has prolonged nowadays, interest has increased to change patterns of life, which include improving the consequences of skin ageing through slowing the ageing process. There are two main processes of skin ageing either intrinsic or extrinsic. Intrinsic ageing reflects genetic background in which skin appears thin with exaggerated expression lines. However, extrinsic ageing is caused by external factors such as smoking, excessive use of alcohol, poor nutrition and sun exposure. Extrinsically aged skin appears predominantly not only by wrinkles, but also by pigmented lesions such as freckles, lentigines and patchy hyperpigmentation, and depigmented lesions such as guttate hypomelanosis. Epidermal and dermal atrophy, rough skin texture, flushing, erythema, telangiectasias, dilated pores and loss of tone and elasticity are also other signs of skin aging. Over the past few years, the use of Mesobotox has broadened and it is now commonly used as rejuvenation procedure with different dilutions. Our work aimed to compare between three commonly used dilutions of Mesobotox regarding its efficacy and safety, as this comparison was not done previously. Aim of the study The aim of this work is to evaluate and compare between different dilutions of Mesobotox in mid and / or lower facial rejuvenation. Patients and methods We included 30 patients complaining of facial wrinkles. Patients were divided into three equal groups to study three different dilutions of Mesobotox 1:5, 1:7 and 1:10. Assessment of treatment response was done using 3D Antera camera. Results Assessment of treatment response using Antera camera in 1:5 dilution revealed statistically significant improvement in all the parameters (periorbital and midface) with more evident improvement after 1 month of treatment compared to after 6 months of treatment. With 1:7 dilution and 1:10 dilution, response revealed statistically significant improvement in most of the parameters (periorbital and midface) with more evident improvement after 1 month of treatment compared to after 6 months of treatment.